遇见数据集

A Multicenter, Randomized, Double-Blind, Prospective, Parallel Study to Compare the Safety and Efficacy of Fenofibrate or Ezetimibe as Add-On Therapy to Atorvastatin in Subjects With Combined Hyperlipidemia, Typical of the Metabolic Syndrome

收藏
DataCite Commons2024-12-02 更新2026-05-07 收录
官方服务:

资源简介:

The objective of this study is to evaluate the effects of adding Tricor 145 mg to once daily atorvastatin 20 mg on CHD lipid laboratory parameters.

提供机构:
Vivli
创建时间:
2018-10-27
二维码
社区交流群
二维码
科研交流群
商业服务